Adiponectin in chronic heart failure: Influence of diabetes and genetic variants

Serge Masson, Francesca Gori, Roberto Latini, Valentina Milani, Allan Flyvbjerg, Jan Frystyk, Luisa Crociati, Silvia Pietri, Tarcisio Vago, Simona Barlera, Aldo P. Maggioni, Gianni Tognoni, Luigi Tavazzi, Torbjørn Omland, Maria Grazia Franzosi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background We hypothesized that, besides type 2 diabetes (T2D) and body mass index (BMI), circulating adiponectin concentration would be associated with variants of the ADIPOQ gene in patients with chronic heart failure (CHF). We also assessed the influence of these confounders on the prognostic value of adiponectin. Methods Plasma adiponectin was measured at entry and after 3months in approximately 1200 patients with CHF enrolled in the GISSI-HF trial. Four common single-nucleotide polymorphisms (SNPs) spanning the ADIPOQ gene were studied: rs17300539 (-11391G→A), rs266729 (-11377C→G), rs2241766 (+45T→G) and rs1501299 (+276G→T). Associations with clinical characteristics and mortality were evaluated in patients with or without T2D. Results Adiponectin concentrations were negatively related to BMI, higher in women and older persons, but lower in patients with diabetes. T-allele carriers for rs1501299 and A-allele carriers for rs17300539 had significantly elevated adiponectin concentrations. Irrespective of diabetes, baseline plasma adiponectin was independently associated with mortality (adjusted HR [95%CI] per 1SD increase in adiponectin concentration=1·24[1·12-1·37], P

Original languageEnglish
Pages (from-to)1330-1338
Number of pages9
JournalEuropean Journal of Clinical Investigation
Volume41
Issue number12
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Adiponectin
Medical problems
Heart Failure
Type 2 Diabetes Mellitus
Body Mass Index
Genes
Alleles
Plasmas
Mortality
Polymorphism
Single Nucleotide Polymorphism
Nucleotides

Keywords

  • Adiponectin
  • Chronic heart failure
  • Clinical trial
  • Diabetes
  • Prognosis
  • Single-nucleotide polymorphism

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry
  • Biochemistry

Cite this

Adiponectin in chronic heart failure : Influence of diabetes and genetic variants. / Masson, Serge; Gori, Francesca; Latini, Roberto; Milani, Valentina; Flyvbjerg, Allan; Frystyk, Jan; Crociati, Luisa; Pietri, Silvia; Vago, Tarcisio; Barlera, Simona; Maggioni, Aldo P.; Tognoni, Gianni; Tavazzi, Luigi; Omland, Torbjørn; Franzosi, Maria Grazia.

In: European Journal of Clinical Investigation, Vol. 41, No. 12, 12.2011, p. 1330-1338.

Research output: Contribution to journalArticle

Masson, S, Gori, F, Latini, R, Milani, V, Flyvbjerg, A, Frystyk, J, Crociati, L, Pietri, S, Vago, T, Barlera, S, Maggioni, AP, Tognoni, G, Tavazzi, L, Omland, T & Franzosi, MG 2011, 'Adiponectin in chronic heart failure: Influence of diabetes and genetic variants', European Journal of Clinical Investigation, vol. 41, no. 12, pp. 1330-1338. https://doi.org/10.1111/j.1365-2362.2011.02548.x
Masson, Serge ; Gori, Francesca ; Latini, Roberto ; Milani, Valentina ; Flyvbjerg, Allan ; Frystyk, Jan ; Crociati, Luisa ; Pietri, Silvia ; Vago, Tarcisio ; Barlera, Simona ; Maggioni, Aldo P. ; Tognoni, Gianni ; Tavazzi, Luigi ; Omland, Torbjørn ; Franzosi, Maria Grazia. / Adiponectin in chronic heart failure : Influence of diabetes and genetic variants. In: European Journal of Clinical Investigation. 2011 ; Vol. 41, No. 12. pp. 1330-1338.
@article{0368dddccc044c3993b00d7a27e6d058,
title = "Adiponectin in chronic heart failure: Influence of diabetes and genetic variants",
abstract = "Background We hypothesized that, besides type 2 diabetes (T2D) and body mass index (BMI), circulating adiponectin concentration would be associated with variants of the ADIPOQ gene in patients with chronic heart failure (CHF). We also assessed the influence of these confounders on the prognostic value of adiponectin. Methods Plasma adiponectin was measured at entry and after 3months in approximately 1200 patients with CHF enrolled in the GISSI-HF trial. Four common single-nucleotide polymorphisms (SNPs) spanning the ADIPOQ gene were studied: rs17300539 (-11391G→A), rs266729 (-11377C→G), rs2241766 (+45T→G) and rs1501299 (+276G→T). Associations with clinical characteristics and mortality were evaluated in patients with or without T2D. Results Adiponectin concentrations were negatively related to BMI, higher in women and older persons, but lower in patients with diabetes. T-allele carriers for rs1501299 and A-allele carriers for rs17300539 had significantly elevated adiponectin concentrations. Irrespective of diabetes, baseline plasma adiponectin was independently associated with mortality (adjusted HR [95{\%}CI] per 1SD increase in adiponectin concentration=1·24[1·12-1·37], P",
keywords = "Adiponectin, Chronic heart failure, Clinical trial, Diabetes, Prognosis, Single-nucleotide polymorphism",
author = "Serge Masson and Francesca Gori and Roberto Latini and Valentina Milani and Allan Flyvbjerg and Jan Frystyk and Luisa Crociati and Silvia Pietri and Tarcisio Vago and Simona Barlera and Maggioni, {Aldo P.} and Gianni Tognoni and Luigi Tavazzi and Torbj{\o}rn Omland and Franzosi, {Maria Grazia}",
year = "2011",
month = "12",
doi = "10.1111/j.1365-2362.2011.02548.x",
language = "English",
volume = "41",
pages = "1330--1338",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Blackwell Publishing Ltd",
number = "12",

}

TY - JOUR

T1 - Adiponectin in chronic heart failure

T2 - Influence of diabetes and genetic variants

AU - Masson, Serge

AU - Gori, Francesca

AU - Latini, Roberto

AU - Milani, Valentina

AU - Flyvbjerg, Allan

AU - Frystyk, Jan

AU - Crociati, Luisa

AU - Pietri, Silvia

AU - Vago, Tarcisio

AU - Barlera, Simona

AU - Maggioni, Aldo P.

AU - Tognoni, Gianni

AU - Tavazzi, Luigi

AU - Omland, Torbjørn

AU - Franzosi, Maria Grazia

PY - 2011/12

Y1 - 2011/12

N2 - Background We hypothesized that, besides type 2 diabetes (T2D) and body mass index (BMI), circulating adiponectin concentration would be associated with variants of the ADIPOQ gene in patients with chronic heart failure (CHF). We also assessed the influence of these confounders on the prognostic value of adiponectin. Methods Plasma adiponectin was measured at entry and after 3months in approximately 1200 patients with CHF enrolled in the GISSI-HF trial. Four common single-nucleotide polymorphisms (SNPs) spanning the ADIPOQ gene were studied: rs17300539 (-11391G→A), rs266729 (-11377C→G), rs2241766 (+45T→G) and rs1501299 (+276G→T). Associations with clinical characteristics and mortality were evaluated in patients with or without T2D. Results Adiponectin concentrations were negatively related to BMI, higher in women and older persons, but lower in patients with diabetes. T-allele carriers for rs1501299 and A-allele carriers for rs17300539 had significantly elevated adiponectin concentrations. Irrespective of diabetes, baseline plasma adiponectin was independently associated with mortality (adjusted HR [95%CI] per 1SD increase in adiponectin concentration=1·24[1·12-1·37], P

AB - Background We hypothesized that, besides type 2 diabetes (T2D) and body mass index (BMI), circulating adiponectin concentration would be associated with variants of the ADIPOQ gene in patients with chronic heart failure (CHF). We also assessed the influence of these confounders on the prognostic value of adiponectin. Methods Plasma adiponectin was measured at entry and after 3months in approximately 1200 patients with CHF enrolled in the GISSI-HF trial. Four common single-nucleotide polymorphisms (SNPs) spanning the ADIPOQ gene were studied: rs17300539 (-11391G→A), rs266729 (-11377C→G), rs2241766 (+45T→G) and rs1501299 (+276G→T). Associations with clinical characteristics and mortality were evaluated in patients with or without T2D. Results Adiponectin concentrations were negatively related to BMI, higher in women and older persons, but lower in patients with diabetes. T-allele carriers for rs1501299 and A-allele carriers for rs17300539 had significantly elevated adiponectin concentrations. Irrespective of diabetes, baseline plasma adiponectin was independently associated with mortality (adjusted HR [95%CI] per 1SD increase in adiponectin concentration=1·24[1·12-1·37], P

KW - Adiponectin

KW - Chronic heart failure

KW - Clinical trial

KW - Diabetes

KW - Prognosis

KW - Single-nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=81355149888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81355149888&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2362.2011.02548.x

DO - 10.1111/j.1365-2362.2011.02548.x

M3 - Article

C2 - 21623778

AN - SCOPUS:81355149888

VL - 41

SP - 1330

EP - 1338

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 12

ER -